The Impact of Gamma Stimulation on Neurological Phenotypes of Alzheimer's Dementia and Down Syndrome
Name
jackson-brennan-phd-hst-2023-thesis.pdf
Description
Thesis PDF
Size
107.11 MB
Format
Adobe PDF
Checksum (MD5)
954ac1fa1c597667968f85a76d1ab5e3
Author(s)
Jackson, Brennan
Advisor(s)
Tsai, Li-Huei
Date Issued
September 2023
Publisher
Massachusetts Institute of Technology
Abstract
Non-invasive Gamma ENtrainment Using Sensory stimulation (GENUS) at 40Hz reduced Alzheimer’s disease (AD) pathology such as amyloid and tau levels, prevented cerebral atrophy, and improved behavioral testing performance in mouse models of AD. This thesis work focuses on the translation of this intervention into human patients with AD. Initial pilot studies assessed safety, compliance, entrainment and exploratory clinical outcomes in patients with mild AD during acute and chronic exposure to GENUS. Additionally, due to the increase in amyloid burden and other shared biological and cognitive phenotypes present in the setting of trisomy 21 compared to AD, we also present initial investigation into the use of GENUS in adult Ts65Dn mice, a mouse model of Down syndrome (DS). Chronic exposure resulted in significant genetic and immunohistochemical changes related to synapse organization and adult neurogenesis within the hippocampus, as well as an improvement in spatial memory during behavioral testing. Finally, we also share pilot studies in human individuals with DS to show initial safety, compliance, and entrainment data from acute exposure experiments. Overall, GENUS offers a promising, non-invasive method for altering gamma frequency activity in hippocampal and cortical neuronal circuits and improving cognitive performance in the setting of AD and DS.
MIT Department
Harvard-MIT Program in Health Sciences and Technology
Terms of Use
In Copyright - Educational Use Permitted
Copyright retained by author(s)
Persistent DSpace Link
